BioNTech partners with UK government

Thursday 12 January 2023


Germany-based BioNTech SE, which together with Pfizer Inc commercialised the first Covid-19 vaccine, has entered into a partnership with the UK government to research and develop mRNA vaccines for other diseases. The multi-year collaboration will include the development of vaccines for cancer and infectious diseases. For cancer, the goal is to be able to provide personalised cancer therapies for up to 10,000 patients by the end of 2030, either in clinical trials or as authorised treatments.